Skip to main content

Table 3 League table showing pairwise comparisons for all surgical approaches and end points included in the quantitative network meta-analysis

From: Surgical approaches for treatment of ureteropelvic junction obstruction – a systematic review and network meta-analysis

End pointEndopyelotomy (reference)Laparoscopic pyeloplasty (reference)Open pyeloplasty (reference)Robot assisted laparoscopic pyeloplasty (reference)
operative success (OR)EP (comparator)1 (1–1), p = NA0.18 (0.11–0.31), p = < 0.0010.14 (0.07–0.27), p = < 0.0010.09 (0.05–0.19), p = < 0.001
LP (comparator)5.44 (3.26–9.08), p = < 0.0011 (1–1), p = NA0.74 (0.44–1.26), p = 0.270.51 (0.31–0.84), p = 0.008
OP (comparator)7.31 (3.72–14.39), p = < 0.0011.34 (0.8–2.27), p = 0.271 (1–1), p = NA0.69 (0.34–1.4), p = 0.306
RP (comparator)10.59 (5.25–21.37), p = < 0.0011.94 (1.19–3.19), p = 0.0081.45 (0.71–2.94), p = 0.3061 (1–1), p = NA
  EP (reference)LP (reference)OP (reference)RP (reference)
overall complications (OR)EP (comparator)1 (1–1), p = NA0.95 (0.41–2.18), p = 0.8980.59 (0.25–1.39), p = 0.2261.43 (0.54–3.78), p = 0.474
LP (comparator)1.06 (0.46–2.43), p = 0.8981 (1–1), p = NA0.62 (0.41–0.95), p = 0.0271.51 (0.91–2.51), p = 0.115
OP (comparator)1.7 (0.72–4.01), p = 0.2261.61 (1.05–2.45), p = 0.0271 (1–1), p = NA2.42 (1.27–4.63), p = 0.007
RP (comparator)0.7 (0.26–1.85), p = 0.4740.66 (0.4–1.1), p = 0.1150.41 (0.22–0.79), p = 0.0071 (1–1), p = NA
  EP (reference)LP (reference)OP (reference)RP (reference)
urinary leakage (OR)EP (comparator)1 (1–1), p = NA0.14 (0.01–3.01), p = 0.2110.17 (0.01–3.41), p = 0.2470.25 (0.01–5.95), p = 0.392
LP (comparator)6.98 (0.33–146.48), p = 0.2111 (1–1), p = NA1.19 (0.39–3.62), p = 0.7611.75 (0.74–4.17), p = 0.206
OP (comparator)5.87 (0.29–117.38), p = 0.2470.84 (0.28–2.56), p = 0.7611 (1–1), p = NA1.47 (0.36–6.05), p = 0.591
RP (comparator)3.99 (0.17–94.46), p = 0.3920.57 (0.24–1.36), p = 0.2060.68 (0.17–2.79), p = 0.5911 (1–1), p = NA
  EP (reference)LP (reference)OP (reference)RP (reference)
re-operation (OR)EP (comparator)1 (1–1), p = NA6.18 (0.97–39.29), p = 0.0534.75 (0.7–32.39), p = 0.11219.18 (0.46–800.12), p = 0.121
LP (comparator)0.16 (0.03–1.03), p = 0.0531 (1–1), p = NA0.77 (0.32–1.85), p = 0.5573.1 (0.12–79.23), p = 0.494
OP (comparator)0.21 (0.03–1.43), p = 0.1121.3 (0.54–3.14), p = 0.5571 (1–1), p = NA4.04 (0.14–116), p = 0.415
RP (comparator)0.05 (0–2.17), p = 0.1210.32 (0.01–8.24), p = 0.4940.25 (0.01–7.11), p = 0.4151 (1–1), p = NA
  EP (reference)LP (reference)OP (reference)RP (reference)
transfusion rate (OR)EP (comparator)1 (1–1), p = NA2.74 (0.33–22.72), p = 0.350.78 (0.07–9.02), p = 0.8446.17 (0.14–273.11), p = 0.347
LP (comparator)0.36 (0.04–3.03), p = 0.351 (1–1), p = NA0.29 (0.04–2.16), p = 0.2252.25 (0.1–52.29), p = 0.613
OP (comparator)1.28 (0.11–14.72), p = 0.8443.5 (0.46–26.44), p = 0.2251 (1–1), p = NA7.88 (0.19–331.49), p = 0.279
RP (comparator)0.16 (0–7.18), p = 0.3470.44 (0.02–10.32), p = 0.6130.13 (0–5.34), p = 0.2791 (1–1), p = NA
  EP (reference)LP (reference)OP (reference)RP (reference)
operating time (mean minutes and SD) after sensitivity analysesEP (comparator)0 (0–0), p = NA−127.51 (−179.83--75.19), p = < 0.001−76.16 (− 142.85--9.47), p = 0.025−115.39 (− 175.19--55.58), p = < 0.001
LP (comparator)127.51 (75.19–179.83), p = < 0.0010 (0–0), p = NA51.35 (10–92.7), p = 0.01512.12 (− 16.84–41.08), p = 0.412
OP (comparator)76.16 (9.47–142.85), p = 0.025−51.35 (−92.7--10), p = 0.0150 (0–0), p = NA−39.22 (−89.71–11.26), p = 0.128
RP (comparator)115.39 (55.58–175.19), p = < 0.001−12.12 (−41.08–16.84), p = 0.41239.22 (− 11.26–89.71), p = 0.1280 (0–0), p = NA
  EP (reference)LP (reference)OP (reference)RP (reference)
length of stay (mean days and SD)EP (comparator)0 (0–0), p = NA0.32 (−2.55–3.18), p = 0.827−0.69 (−4.76–3.37), p = 0.7391.19 (− 2.52–4.9), p = 0.53
LP (comparator)−0.32 (−3.18–2.55), p = 0.8270 (0–0), p = NA−1.01 (− 3.89–1.87), p = 0.4920.87 (− 1.49–3.23), p = 0.471
OP (comparator)0.69 (− 3.37–4.76), p = 0.7391.01 (− 1.87–3.89), p = 0.4920 (0–0), p = NA1.88 (− 1.85–5.61), p = 0.323
RP (comparator)−1.19 (− 4.9–2.52), p = 0.53−0.87 (− 3.23–1.49), p = 0.471−1.88 (− 5.61–1.85), p = 0.3230 (0–0), p = NA
  1. Estimates with corresponding statistically significant p-values (p < 0.05) are written in boldface